Phillip Lai

1.2k citations
14 papers · 987 · 2 hit papers · h-index 6

Impact in

  • Ophthalmology top 0.5%
    • Retinal Diseases and Treatments
    • Retinal and Optic Conditions
    • Glaucoma and retinal disorders
    • Ocular Diseases and Behçet’s Syndrome
    • Retinal Imaging and Analysis
    • Retinal and Macular Surgery

Papers in

    • Retinal Diseases and Treatments 7
    • Glaucoma and retinal disorders 2
    • Retinal and Optic Conditions 2
    • Retinal Development and Disorders 3
    • RNA regulation and disease 2

Phillip Lai

13 papers receiving 952 citations

Phillip Lai's Hit Papers

Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration 2014 · 492 citations
4920+4+9Years since publication100200300400

Peers

Phillip Lai
Comparison fields: 5 of 48
  • Ophthalmology 863
  • Radiology, Nuclear Medicine and Imaging 248
  • Neurology 28
  • Neurology 10
  • Molecular Biology 86
Replace Michael Tolentino with:
Michael Tolentino United States
James Warburton Switzerland
Lucian Del Priore United States
Siamak Ansari‐Shahrezaei Austria
Yehia Hashad United States
Yukihiko Suzuki Japan
Prema Abraham United States
Ana Rita Santos Portugal
David R. Lally United States
Arif Samad Canada
Phillip Lai relative to Michael Tolentino United States Michael Tolentino's profile →
Citations per field
00.5×
Michael Tolentino · 1×
Citations per year

Countries citing papers authored by Phillip Lai

Since Specialization
Citations

This map shows the geographic impact of Phillip Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Lai more than expected).

Fields of papers citing papers by Phillip Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Lai. The network helps show where Phillip Lai may publish in the future.

Co-authors

The 25 scholars most cited alongside Phillip Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Phillip Lai Line = papers co-authored together Phillip Lai links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration
Hit paper breakdown →
2014492
2
Ranibizumab for Macular Edema Due to Retinal Vein Occlusions
Hit paper breakdown →
2012378
3 202042
4 202326
5 202124
6 20205
7 20235
8
A Common SNP at the CFI Locus is Associated with Rapid Progression of Geographic Atrophy
20144
9 20124
10
Meta-analysis examining the systemic safety profile of intravitreal ranibizumab injections in AMD, RVO and DME
20133
11
Initial lesion growth rates and other baseline prognostic factors can improve the design of clinical trials in Geographic Atrophy (GA)
20202
12
Phase 1 safety study of intravitreal (ITV) Anti-High Temperature Requirement A1 (aHtrA1), a novel serine protease inhibitor, in patients with Geographic Atrophy (GA)
20201
13
Functional and Ultrastructural Assessment of Novel OCT Findings in the Cynomolgus Monkey
20191
14 20250

About Phillip Lai

Phillip Lai is a scholar working on Ophthalmology, Molecular Biology, Neurology, Radiology, Nuclear Medicine and Imaging and Biophysics, having authored 14 papers that have together received 987 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (7 papers), Retinal Development and Disorders (3 papers), Cerebrovascular and genetic disorders (3 papers), Glaucoma and retinal disorders (2 papers), Retinal Imaging and Analysis (2 papers), Retinal and Optic Conditions (2 papers), RNA regulation and disease (2 papers) and Advanced Fluorescence Microscopy Techniques (1 paper). The work is most often cited by research in Ophthalmology (863 citations), Radiology, Nuclear Medicine and Imaging (248 citations), Neurology (28 citations), Neurology (10 citations) and Molecular Biology (86 citations). Phillip Lai has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Roman G. Rubio, Zhengrong Li, Mark R. Wieland, Carl D. Regillo, Allen C. Ho, Brandon Busbee, Linda Yau, Peter A. Campochiaro, Namrata Saroj and Jeffrey S. Heier. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Ophthalmology, American Journal of Ophthalmology, The Journal of Laryngology & Otology and Toxicologic Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact